Physiologic Effects of High-Flow Nasal Cannula in Healthy Subjects
- 14 April 2020
- journal article
- research article
- Published by Daedalus Enterprises in Respiratory Care
- Vol. 65 (9), 1346-1354
- https://doi.org/10.4187/respcare.07306
Abstract
BACKGROUND: High-flow nasal cannula (HFNC) is increasingly used in the management of acute and chronic respiratory failure. Little is known about the optimal settings for HFNC. This study was designed to assess the dose effect of HFNC on respiratory effort indexes and respiratory patterns in spontaneously breathing adults. METHODS: A randomized controlled crossover study was conducted in 10 healthy subjects. Five experimental conditions were evaluated: baseline with no therapy; 5 L/min with conventional nasal prongs; and HFNC at 20, 40, and 60 L/min. The primary outcomes were the indexes of respiratory effort (ie, esophageal pressure swing [ΔPes], esophageal pressure-time product, and work of breathing). Secondary outcomes included breathing pattern parameters and blood gases. Dead-space ventilation and washout were calculated based on minute ventilation, breathing frequency, and Radford equations. RESULTS: ΔPes increased from median (interquartile range [IQR] 3.2 (2.2–3.6) cm H2O at baseline to median (IQR) 5.7 (4.6–6.8) cm H2O at 60 L/min (P < .001). Neither esophageal pressure-time product nor work of breathing were modified during the tested conditions. The minute volume was significantly reduced at 40 and 60 L/min compared with baseline (P = .04), mostly driven by an important and dose-dependent reduction in breathing frequency, from median (IQR) 16 (15–18) breaths/min at baseline, to median (IQR) 8 (7–10) breaths/min at 60 L/min (P < .001). Capillary PCO2 was stable in all the tested conditions. The calculated dead-space ventilation was reduced by half with HFNC. CONCLUSIONS: HFNC did not significantly modify work of breathing in healthy subjects. However, a significant reduction in the minute volume was achieved, capillary PCO2 remaining constant, which suggests a reduction in dead-space ventilation with flows > 20 L/min. (ClinicalTrials.gov registration NCT02495675).Keywords
This publication has 41 references indexed in Scilit:
- Mechanisms of nasal high flow on ventilation during wakefulness and sleepJournal of Applied Physiology, 2013
- Effect of High-Flow Nasal Cannula and Body Position on End-Expiratory Lung Volume: A Cohort Study Using Electrical Impedance TomographyRespiratory Care, 2013
- Pressures Delivered By Nasal High Flow Oxygen During All Phases of the Respiratory CycleRespiratory Care, 2013
- Effects of Nasal High Flow on Ventilation in Volunteers, COPD and Idiopathic Pulmonary Fibrosis PatientsRespiration, 2012
- Effects of Nasal Insufflation on Arterial Gas Exchange and Breathing Pattern in Patients with Chronic Obstructive Pulmonary Disease and Hypercapnic Respiratory FailureAdvances in Experimental Medicine and Biology, 2012
- Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patientsBritish Journal of Anaesthesia, 2011
- Unsteady flow in the nasal cavity with high flow therapy measured by stereoscopic PIVExperiments in Fluids, 2011
- The clinical utility of long-term humidification therapy in chronic airway diseaseRespiratory Medicine, 2010
- Research in high flow therapy: Mechanisms of actionRespiratory Medicine, 2009
- Arterial versus capillary blood gases: A meta-analysisRespiratory Physiology & Neurobiology, 2007